Inhibiteurs de tyrosine kinase ciblant le VEGFR

Author： Loriot Y.   Massard C.   Armand J.-P.  

Publisher： Springer Publishing Company

ISSN： 1292-3818

Source： Oncologie, Vol.8, Iss.9, 2006-11, pp. : 815-820

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ciblage du récepteur aux facteurs de croissance épithéliaux (REGF) par les inhibiteurs de tyrosine kinase et applications dans les cancers colorectaux

By Magné N.   Toillon R.-A.  

Oncologie, Vol. 6, Iss. 1, 2004-02 ,pp. : 41-45

Springer Publishing Company

Access to resources Recommend Favorite

Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma

By Chuah Benjamin   Yeo Wee-Lee   Guo Jia Yi   Lim Seng-Gee   Yap Hui-Ling   Goh Boon-Cher   Lee Soo-Chin  

Acta Oncologica, Vol. 48, Iss. 4, 2009-05 ,pp. : 628-630

Informa Healthcare

Access to resources Recommend Favorite

Apport des antiangiogéniques et des inhibiteurs de mTOR dans le traitement des tumeurs endocrines digestives

By Walter T.   Lombard-Bohas C.  

Oncologie, Vol. 12, Iss. 10, 2010-10 ,pp. : 636-640

Springer Publishing Company

Access to resources Recommend Favorite

Les inhibiteurs de mTOR

By Cortot A.   Soria J.-C.  

Oncologie, Vol. 8, Iss. 9, 2006-11 ,pp. : 821-827

Springer Publishing Company

Access to resources Recommend Favorite

Abl tyrosine protein kinase

By Laneuville P.  

Seminars in Immunology, Vol. 7, Iss. 4, 1995-04 ,pp. : 255-266

Academic Press

Access to resources Recommend Favorite